Pharmacokinetics and Pharmacodynamics Practice Questions

Q: Which of the following drugs can be administered through all routes?

Fentanyl. **Explanation:** **Fentanyl** is the correct answer because it is a highly lipophilic opioid with high potency, allowing it to be formulated for virtually every route of administration. Its pharmacological profile supports: * **Parenteral:** IV, IM, and Epidural/Intrathecal (common in anesthesia). * **Transdermal:** Patches for chronic pain management. * **Transmucosal:** Buccal tablets, lozenges ("lollipop"), and sublingual sprays. * **Intranasal:** Used for breakthrough pain. * **Nebulization:** Occasionally used for dyspnea in palliative care. **Why the other options are incorrect:** * **Paracetamol:** While available as Oral, Rectal, and IV (Parven), it is **not** administered via transdermal or inhalational routes due to its chemical properties and the high dosage required for efficacy. * **Penicillin G:** It is acid-labile and destroyed by gastric acid, making it unsuitable for the **oral** route (unlike Penicillin V). It is primarily given IM or IV. * **Azithromycin:** It is available via Oral and IV routes. However, it lacks transdermal, sublingual, or routine inhalational formulations. **NEET-PG High-Yield Pearls:** * **Lipophilicity:** Fentanyl is 100 times more potent than morphine; its high lipid solubility is the key reason it can cross the skin (transdermal) and mucous membranes easily. * **First-Pass Metabolism:** Fentanyl undergoes extensive hepatic first-pass metabolism, which is why the oral (swallowed) route is ineffective, necessitating transmucosal (buccal/sublingual) delivery to bypass the liver. * **Context-Sensitive Half-Life:** Fentanyl’s duration of action increases significantly with prolonged infusions, a critical concept in ICU sedation.

Q: Atracurium is primarily eliminated by which mechanism?

Nonenzymatic degradation. **Explanation:** **Atracurium** is a benzylisoquinolinium neuromuscular blocking agent unique for its organ-independent elimination. The correct answer is **Nonenzymatic degradation**, specifically a process known as **Hofmann elimination**. 1. **Why Option C is Correct:** Atracurium undergoes spontaneous molecular breakdown at physiological pH and temperature (Hofmann elimination). It is also metabolized by **ester hydrolysis** via non-specific plasma esterases. Because it does not rely on organ function for clearance, it is the drug of choice for patients with **renal or hepatic failure**. 2. **Why Other Options are Incorrect:** * **Option A & B:** While most muscle relaxants (like Vecuronium or Pancuronium) depend on the kidneys or liver for excretion, Atracurium’s primary pathway bypasses these organs. Impairment in renal or hepatic function does not significantly prolong its duration of action. * **Option D:** Since the primary and clinically significant route is nonenzymatic, "All of the above" is incorrect. **High-Yield Clinical Pearls for NEET-PG:** * **Laudanosine Toxicity:** Hofmann elimination produces a metabolite called *Laudanosine*. In high concentrations (prolonged infusions), it can cross the blood-brain barrier and act as a **CNS stimulant**, potentially causing **seizures**. * **Cisatracurium:** An isomer of atracurium that is more potent, produces less laudanosine, and does not cause **histamine release** (unlike atracurium, which can cause flushing and hypotension). * **Temperature/pH Sensitivity:** Since Hofmann elimination is spontaneous, the rate of degradation increases with hyperthermia/alkalosis and decreases with hypothermia/acidosis.

Q: All of the following cause inhibition of CYP3A except?

Saquinavir. ### Explanation The Cytochrome P450 (CYP) system, specifically the **CYP3A4** isoform, is responsible for the metabolism of over 50% of clinically used drugs. Understanding its inhibitors and inducers is a high-yield topic for NEET-PG. **Why Saquinavir is the correct answer:** While most Protease Inhibitors (PIs) are known to interact with the CYP system, **Saquinavir** is primarily a **substrate** of CYP3A4 rather than a potent inhibitor. In clinical practice, Saquinavir has such poor bioavailability that it must be "boosted" by another PI (Ritonavir) to reach therapeutic levels. Unlike Ritonavir, it does not significantly inhibit the metabolism of other drugs. **Analysis of Incorrect Options:** * **Ritonavir (Option B):** This is the **most potent inhibitor** of CYP3A4 among the protease inhibitors. It is used pharmacologically in "low doses" specifically to inhibit the metabolism of other PIs (like Lopinavir or Saquinavir), thereby increasing their plasma concentrations (PK boosting). * **Itraconazole (Option C):** Azole antifungals (especially Ketoconazole and Itraconazole) are classic, potent inhibitors of CYP3A4. They frequently cause drug-drug interactions with statins and warfarin. * **Erythromycin (Option D):** Macrolide antibiotics (except Azithromycin) are notorious CYP3A4 inhibitors. They can lead to toxicity of co-administered drugs like Theophylline or Carbamazepine. **NEET-PG High-Yield Pearls:** * **Mnemonic for CYP3A4 Inhibitors (VITAMIN G):** **V**erapamil, **I**traconazole (and other azoles), **T**elithromycin/Tetracycline, **A**miodarone, **M**acrolides (excluding Azithromycin), **I**nhibitors of HIV Protease (**Ritonavir**), **N**efazodone, **G**rapefruit juice. * **The "Azithromycin Exception":** Among macrolides, Azithromycin does not inhibit CYP enzymes and is the safest choice regarding drug interactions. * **Rifampicin** is the most potent universal **inducer** of CYP enzymes.

Question 1

Which of the following drugs can be administered through all routes?

Accepted Answer

Fentanyl

Answer

Paracetamol

Answer

Penicillin G

Answer

Azithromycin

Question 2

Tubular secretion of a drug can be confirmed if its renal clearance is:

Accepted Answer

More than the glomerular filtration rate (GFR)

Answer

Equal to the glomerular filtration rate (GFR)

Answer

Less than the glomerular filtration rate (GFR)

Answer

More than the volume of distribution

Question 3

Atracurium is primarily eliminated by which mechanism?

Accepted Answer

Nonenzymatic degradation

Answer

Renal excretion

Answer

Hepatic elimination

Answer

All of the above

Question 4

A drug with a plasma half-life of 12 hours is administered twice a day. Steady-state plasma concentration reached is 300 mg/dl. Which of the following statements about this drug is not true?

Accepted Answer

Intravenous administration will always achieve a higher concentration than the oral route.

Answer

Plasma concentration will be approximately 260 mg/dl after three half-lives of initiation of therapy.

Answer

After changing the dose, plasma concentration should be measured after 3 days.

Answer

Doubling the dose will double the plasma concentration after 3 days.

Question 5

All of the following cause inhibition of CYP3A except?

Accepted Answer

Saquinavir

Answer

Ritonavir

Answer

Itraconazole

Answer

Erythromycin

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?